COMPANY OVERVIEW

IRX Therapeutics is a clinical-stage bioresearch company developing IRX-2, an important new immunotherapy candidate for cancer.

---

LOCATION

New York, NY, USA

Brooklyn, NY, USA

---

THERAPEUTIC AREAS

Oncology

---

WEBSITE

https://irxtherapeutics.com/

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Nov 7, 2018

Brooklyn ImmunoTherapeutics Acquires IRX Therapeutics

Feb 14, 2018

IRX Therapeutics Announces Initiation of Phase 2 Clinical Trial of IRX-2 in Squamous Cervical or Vulvar Intraepithelial Neoplasia 3

Nov 15, 2017

IRX Therapeutics Appoints Luba Greenwood to Board of Directors

Nov 10, 2017

IRX Therapeutics Announces Presentation of IRX-2 Phase 1b Biomarker Data in Early Stage Breast Cancer

Sep 11, 2017

IRX Therapeutics Presents Positive IRX-2 Phase 2a Head and Neck Squamous Cell Carcinoma Clinical Results at the European Society for Medical Oncology Annual Congress 2017

For More Press Releases

---